Verano Holdings (VRNO) Inventory Average (2022 - 2026)
Verano Holdings' (VRNO) quarterly Inventory Average came in at $232.8 million in Q1 2026, up 23.58% year-on-year from $188.4 million in Q1 2025, and up 3.53% on a QoQ basis from $224.8 million in Q4 2025.
Verano Holdings (VRNO) Inventory Average (2022 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 5 years of Inventory Average data on file, last reported at $232.8 million in Q1 2026.
- On a quarterly basis, Inventory Average rose 23.58% year-over-year to $232.8 million in Q1 2026; TTM through Mar 2026 was $232.8 million, a 23.58% increase from a year earlier, with the FY2025 full-year figure at $207.2 million, up 21.81% from the prior year.
- Inventory Average for Q1 2026 stood at $232.8 million, up from $224.8 million in the prior quarter.
- Over the last five years, Inventory Average for VRNO reached as high as $232.8 million in Q1 2026 and fell as low as $3.5 million in Q1 2022.
- Historically, Inventory Average has averaged $163.8 million across 5 years, with a median of $166.3 million in 2022.
- On a YoY basis, Inventory Average climbed as much as 4466.37% in 2023 and fell as far as 8.22% in 2023.
- Year by year, Inventory Average stood at $166.3 million in 2022, then slipped by 7.84% to $153.3 million in 2023, then grew by 23.46% to $189.3 million in 2024, then rose by 18.81% to $224.8 million in 2025, then rose by 3.53% to $232.8 million in 2026.
- Per Business Quant data, the three most recent Inventory Average figures were $232.8 million in Q1 2026, $224.8 million in Q4 2025, and $217.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.45 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.18 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.51 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 9.02 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 180.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.11 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.96 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 66.75 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.73 Bn |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn | 232.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 232.77 Mn |
| Dec 31, 2025 | 224.84 Mn |
| Sep 30, 2025 | 217.03 Mn |
| Jun 30, 2025 | 203.30 Mn |
| Mar 31, 2025 | 188.36 Mn |
| Dec 31, 2024 | 189.25 Mn |
| Sep 30, 2024 | 181.70 Mn |
| Jun 30, 2024 | 167.77 Mn |
| Mar 31, 2024 | 160.97 Mn |
| Dec 31, 2023 | 153.29 Mn |
| Sep 30, 2023 | 147.85 Mn |
| Jun 30, 2023 | 149.25 Mn |
| Mar 31, 2023 | 159.07 Mn |
| Dec 31, 2022 | 166.34 Mn |
| Sep 30, 2022 | 161.10 Mn |
| Jun 30, 2022 | 78.97 Mn |
| Mar 31, 2022 | 3.48 Mn |